This Edition
ARTICLE | Clinical News
ALX-0081: Phase Ib start
WIR Staff
March 10, 2008 7:00 AM UTC
This year, Ablynx plans to start a multiple-dose Phase Ib trial of ALX-0081 in patients. ...